Close Menu

CYP2C19

The latest analysis of CYP2C19 genotyping to guide antiplatelet therapy tries to address cost questions from the vantage of a payor or large healthcare system.

The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing.

NEW YORK (GenomeWeb) – Health Canada has approved Spartan Bioscience's non-invasive genetic test for determining within an hour whether a person has CYP2C19 genetic mutations.

This article has been updated to note that PDI is moving away from the contract sales business with drug companies. Originally published Oct. 22.

Having published research last year identifying a novel haplotype that may alter the interpretation of CYP2C19 genotyping, clinical researchers from the Icahn School of Medicine at Mount Sinai in New York have now published a paper describing an allele-specific PCR assay to detec

Canadian molecular diagnostics developer Spartan Bioscience said this week that the US Food and Drug Administration has granted 510(k) clearance to the Spartan RX CYP2C19 assay.

Originally published Aug. 19. The University of Florida's experience implementing a pharmacogenetic testing program for clopidogrel is becoming a blueprint for bringing personalized medicine strategies to the community healthcare setting.

Akonni Biosystems this week announced the results of three preclinical studies in support of the efficacy of its TruDiagnosis molecular diagnostics platform and TruArray tests, and said that the platform is now ready for expanded, multi-site clin

Quidel this week received 510(k) clearance from the US Food and Drug Administration for its AmpliVue C. Difficile assay.

The University of Florida Academic Health Center has adopted Life Technologies' QuantStudio 12K Flex real-time PCR system using OpenArray consumable plates to implement a new personalized medicine strategy to screen all incoming catheterization patients for their likelihood of re

Pages

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.